Overview
Epilepsy syndrome is a broad classification term used in Orphanet (ORPHA:166463) to encompass a group of epileptic disorders defined by a cluster of clinical features including seizure types, electroencephalographic (EEG) patterns, age of onset, and associated comorbidities. Epilepsy syndromes affect the central nervous system, specifically the brain, where abnormal electrical activity leads to recurrent, unprovoked seizures. These seizures can manifest in many forms, including generalized tonic-clonic convulsions, absence seizures, focal seizures with or without impaired awareness, myoclonic jerks, and atonic episodes. Depending on the specific syndrome, patients may also experience developmental delay, intellectual disability, behavioral disturbances, and neurological regression. The clinical presentation varies widely across the many recognized epilepsy syndromes. Some syndromes, such as childhood absence epilepsy or juvenile myoclonic epilepsy, are relatively benign and respond well to antiseizure medications, while others, such as Dravet syndrome or Lennox-Gastaut syndrome, are severe epileptic encephalopathies associated with drug-resistant seizures and significant neurodevelopmental impairment. Diagnosis typically involves clinical history, EEG findings, neuroimaging, and increasingly, genetic testing, as many epilepsy syndromes have identified genetic etiologies involving ion channel genes, synaptic proteins, and other neuronal regulatory molecules. Treatment of epilepsy syndromes depends on the specific diagnosis and may include antiseizure medications (such as valproate, levetiracetam, lamotrigine, or ethosuximide), dietary therapies (such as the ketogenic diet), neurostimulation devices (vagus nerve stimulation, responsive neurostimulation), and in selected cases, epilepsy surgery. Emerging precision medicine approaches, including gene-specific therapies, are being developed for certain genetic epilepsy syndromes. Management often requires a multidisciplinary team including neurologists, geneticists, neuropsychologists, and rehabilitation specialists to address the full spectrum of clinical needs.
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
10 eventsUniversity of Iowa — NA
Assiut University
Hospices Civils de Lyon — NA
Yale University — PHASE3
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau — PHASE3
Heather Olson — PHASE1
Boston Children's Hospital
University Medicine Greifswald
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Epilepsy syndrome.
20 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Rare Disease Specialist
Rare Disease Specialist
Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Epilepsy syndrome.
Community
No community posts yet. Be the first to share your experience with Epilepsy syndrome.
Start the conversation →Latest news about Epilepsy syndrome
Disease timeline:
New recruiting trial: A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy
A new clinical trial is recruiting patients for Epilepsy syndrome
New recruiting trial: Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY
A new clinical trial is recruiting patients for Epilepsy syndrome
New recruiting trial: Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy
A new clinical trial is recruiting patients for Epilepsy syndrome
New recruiting trial: SCN1A Horizons A Natural History Study of SCN1A-related Epilepsies in the United Kingdom
A new clinical trial is recruiting patients for Epilepsy syndrome
New recruiting trial: GABA Biomarkers in Dravet Syndrome
A new clinical trial is recruiting patients for Epilepsy syndrome
New recruiting trial: Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
A new clinical trial is recruiting patients for Epilepsy syndrome
New recruiting trial: A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)
A new clinical trial is recruiting patients for Epilepsy syndrome
New recruiting trial: Evaluation of the NaviFUS System in Drug Resistant Epilepsy
A new clinical trial is recruiting patients for Epilepsy syndrome
New recruiting trial: Ketogenic Diet for Prevention of Epileptic Spasms in Infantile Onset Genetic Epilepsies
A new clinical trial is recruiting patients for Epilepsy syndrome
New recruiting trial: A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
A new clinical trial is recruiting patients for Epilepsy syndrome
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Epilepsy syndrome
What is Epilepsy syndrome?
Epilepsy syndrome is a broad classification term used in Orphanet (ORPHA:166463) to encompass a group of epileptic disorders defined by a cluster of clinical features including seizure types, electroencephalographic (EEG) patterns, age of onset, and associated comorbidities. Epilepsy syndromes affect the central nervous system, specifically the brain, where abnormal electrical activity leads to recurrent, unprovoked seizures. These seizures can manifest in many forms, including generalized tonic-clonic convulsions, absence seizures, focal seizures with or without impaired awareness, myoclonic
Are there clinical trials for Epilepsy syndrome?
Yes — 20 recruiting clinical trials are currently listed for Epilepsy syndrome on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Epilepsy syndrome?
25 specialists and care centers treating Epilepsy syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.